Log in

NASDAQ:SSKNSTRATA Skin Sciences Stock Price, Forecast & News

$1.28
+0.06 (+4.92 %)
(As of 05/22/2020 04:00 PM ET)
Add
Compare
Today's Range
$1.24
Now: $1.28
$1.30
50-Day Range
$0.81
MA: $1.15
$1.64
52-Week Range
$0.75
Now: $1.28
$2.92
Volume12,108 shs
Average Volume97,231 shs
Market Capitalization$43.15 million
P/E RatioN/A
Dividend YieldN/A
Beta2.24
STRATA Skin Sciences, Inc., a medical technology company, focuses on the therapeutic and aesthetic dermatology market. The company operates through three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment, and Dermatology Imaging. Its products include XTRAC laser and VTRAC excimer lamp systems used for the treatment of psoriasis, vitiligo, and other skin conditions; the STRATAPEN MicroSystems, a micropigmentation device; and Nordlys, a multi-technology aesthetic laser device for treating vascular and pigmented lesions. STRATA Skin Sciences, Inc. was founded in 1989 and is based in Horsham, Pennsylvania.
Read More
STRATA Skin Sciences logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.49 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SSKN
CUSIPN/A
Phone215-619-3200

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$31.59 million
Cash Flow$0.04 per share
Book Value$0.87 per share

Profitability

Net Income$-3,790,000.00

Miscellaneous

Employees98
Market Cap$43.15 million
Next Earnings Date8/11/2020 (Estimated)
OptionableNot Optionable

Receive SSKN News and Ratings via Email

Sign-up to receive the latest news and ratings for SSKN and its competitors with MarketBeat's FREE daily newsletter.

STRATA Skin Sciences (NASDAQ:SSKN) Frequently Asked Questions

How has STRATA Skin Sciences' stock been impacted by COVID-19 (Coronavirus)?

STRATA Skin Sciences' stock was trading at $1.42 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, SSKN stock has decreased by 9.9% and is now trading at $1.28. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of STRATA Skin Sciences?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for STRATA Skin Sciences in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for STRATA Skin Sciences.

When is STRATA Skin Sciences' next earnings date?

STRATA Skin Sciences is scheduled to release its next quarterly earnings announcement on Tuesday, August 11th 2020. View our earnings forecast for STRATA Skin Sciences.

How were STRATA Skin Sciences' earnings last quarter?

STRATA Skin Sciences Inc (NASDAQ:SSKN) issued its earnings results on Tuesday, May, 12th. The medical device company reported ($0.03) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.05) by $0.02. The medical device company had revenue of $6.73 million for the quarter, compared to the consensus estimate of $6.69 million. STRATA Skin Sciences had a negative return on equity of 12.09% and a negative net margin of 11.27%. View STRATA Skin Sciences' earnings history.

When did STRATA Skin Sciences' stock split? How did STRATA Skin Sciences' stock split work?

Shares of STRATA Skin Sciences reverse split on the morning of Thursday, July 10th 2014. The 1-10 reverse split was announced on Thursday, July 3rd 2014. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, July 9th 2014. An investor that had 100 shares of STRATA Skin Sciences stock prior to the reverse split would have 10 shares after the split.

What guidance has STRATA Skin Sciences issued on next quarter's earnings?

STRATA Skin Sciences updated its first quarter 2020 Pre-Market earnings guidance on Monday, April, 20th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $6.7-6.9 million, compared to the consensus revenue estimate of $6.2 million.

What price target have analysts set for SSKN?

3 equities research analysts have issued 12-month price objectives for STRATA Skin Sciences' shares. Their forecasts range from $5.00 to $6.00. On average, they expect STRATA Skin Sciences' share price to reach $5.42 in the next year. This suggests a possible upside of 323.2% from the stock's current price. View analysts' price targets for STRATA Skin Sciences.

Has STRATA Skin Sciences been receiving favorable news coverage?

News stories about SSKN stock have been trending somewhat positive recently, according to InfoTrie Sentiment Analysis. InfoTrie scores the sentiment of press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. STRATA Skin Sciences earned a news sentiment score of 1.5 on InfoTrie's scale. They also gave news articles about the medical device company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View the latest news aboutSTRATA Skin Sciences.

Who are some of STRATA Skin Sciences' key competitors?

What other stocks do shareholders of STRATA Skin Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other STRATA Skin Sciences investors own include NovaBay Pharmaceuticals (NBY), NovaBay Pharmaceuticals (NBY), Amarin (AMRN), Plug Power (PLUG), Tonix Pharmaceuticals (TNXP), Kopin (KOPN), Onconova Therapeutics (ONTX), Agile Therapeutics (AGRX), Biocept (BIOC) and Capstone Turbine (CPST).

Who are STRATA Skin Sciences' key executives?

STRATA Skin Sciences' management team includes the following people:
  • Dr. Dolev Rafaeli, CEO, Pres & Director (Age 55)
  • Mr. Matthew C. Hill, VP & CFO (Age 50)
  • Mr. Jay Sturm, Corp. Counsel & Corp. Sec. (Age 63)
  • Keith Simeone, VP of Sales
  • Dr. Darrell S. Rigel M.D., Ms, Faad, Chief Medical Advisor (Age 68)

What is STRATA Skin Sciences' stock symbol?

STRATA Skin Sciences trades on the NASDAQ under the ticker symbol "SSKN."

Who are STRATA Skin Sciences' major shareholders?

STRATA Skin Sciences' stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (0.33%). Company insiders that own STRATA Skin Sciences stock include Luann Via, Matthew C Hill and Samuel E Navarro. View institutional ownership trends for STRATA Skin Sciences.

Which institutional investors are buying STRATA Skin Sciences stock?

SSKN stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc.. Company insiders that have bought STRATA Skin Sciences stock in the last two years include Luann Via, Matthew C Hill, and Samuel E Navarro. View insider buying and selling activity for STRATA Skin Sciences.

How do I buy shares of STRATA Skin Sciences?

Shares of SSKN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is STRATA Skin Sciences' stock price today?

One share of SSKN stock can currently be purchased for approximately $1.28.

How big of a company is STRATA Skin Sciences?

STRATA Skin Sciences has a market capitalization of $43.15 million and generates $31.59 million in revenue each year. The medical device company earns $-3,790,000.00 in net income (profit) each year or ($0.11) on an earnings per share basis. STRATA Skin Sciences employs 98 workers across the globe.

What is STRATA Skin Sciences' official website?

The official website for STRATA Skin Sciences is www.strataskinsciences.com.

How can I contact STRATA Skin Sciences?

STRATA Skin Sciences' mailing address is 5 WALNUT GROVE DRIVE SUITE 140, HORSHAM PA, 19044. The medical device company can be reached via phone at 215-619-3200 or via email at [email protected]

This page was last updated on 5/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.